semaglutide shortage 2025 supply news november Semaglutide Market Size, Share & Growth Report, 2035 Pharmaceuticals roundup 2024 Can You Still Get Compounded

This FDA-approved drug is now recognized for its effectiveness in promoting significant weight reduction, making it an ideal solution for individuals looking to lose weight safely and effectively

Now, who's ready to turn those love handles into "I love my handles"

Semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, has seen explosive uptake due to its efficacy in glycemic control, weight loss and cardiometabolic risk reduction, driving multibillion-dollar revenues for originator companies Novo Nordisk (maker of semaglutide products Ozempic and Wegovy) and Eli Lilly (the pharma giant behind the tirzepatide products Mounjaro and Zepbound)

If your main concern is heart health, Wegovy currently has the stronger track record